Condition: Interstitial Cystitis · Chronic Interstitial Cystitis · Bladder Pain Syndrome · Sponsor: Wake Forest University Health Sciences
The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease bladder and pelvic pain as well as other urinary symptoms associated with IC/BPS. There are two sequential Aims in this study and subjects will be recruited to participate in only one Aim. In both Aims, data will be collected at baseline/enrollment, 4-weeks after using PEMF therapy, and 8, 12, and 16 weeks post-enrollment.
This description comes directly from the study's public registry record.
Stephen J Walker, PhD · 336-713-7272 · Stephen.J.Walker@advocatehealth.org
Kaylee A Ferrara, BS · 336-713-1693 · Kaylee.Ferrara@Advocatehealth.org
Always discuss trial participation with your own doctor first.
| Wake Forest University Health Sciences | Winston-Salem, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05149573